Epidemiological and phylogenetic characteristics of influenza b infection in severe acute respiratory infection cases in Beijing, 2014 to 2015

Medicine (United States)

Volumn 94, Issue 52, 2015, Pages

  Pan, Yang ^a   Zhang, Yi ^a   Yang, Peng ^a   Qian, Haiqun ^a   Shi, Weixian ^a   Wu, Shuangsheng ^a   Cui, Shujuan ^a   Zhang, Daitao ^a   Wang, Quanyi ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHINA; CONTROLLED STUDY; FEMALE; GENE; HEMAGGLUTINATION; HUMAN; INFLUENZA A; INFLUENZA B; INFLUENZA B VIRUS; INFORMATION; MAJOR CLINICAL STUDY; MALE; PHYLOGENY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK; SEVERE RESPIRATORY TRACT INFECTION; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TYPING; ADOLESCENT; CHILD; GENETICS; GENOTYPE; INFANT; INFLUENZA, HUMAN; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BEIJING; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PHYLOGENY; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; YOUNG ADULT;

EID: 84954500772     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002399     Document Type: Article

References (29)

1. World Health Organization. A revision of the system of nomenclature for influenza viruses: a WHO memorandum. Bull World Health Organ. 1980;58:585-591.
2. Dowdle WR, Galphin JC, Coleman MT, et al. A simple double immunodiffusion test for typing influenza viruses. Bull World Health Organ. 1974;51:213-215.
3. Rota PA, Wallis TR, Harmon MW, et al. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology. 1990;175:59-68.
4. Matsuzaki Y, Sugawara K, Takashita E, et al. Genetic diversity of influenza B virus: the frequent reassortment and cocirculation of the genetically distinct reassortant viruses in a community. J Med Virol. 2004;74:132-140.
5. Feng L, Shay DK, Jiang Y, et al. Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008. Bull World Health Organ. 2012;90:279-288.
6. Wang H, Fu C, Li K, et al. Influenza associated mortality in Southern China, 2010-2012. Vaccine. 2014;32:973-978.
7. Chan PK, Chan MC, Cheung JL, et al. Influenza B lineage circulation and hospitalization rates in a subtropical city, Hong Kong, 2000-2010. Clin Infect Dis. 2013;56:677-684.
8. Yu H, Huang J, Huai Y, et al. The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010-2012. Influenza Other Respir Viruses. 2014;8:53-65.
9. Peng Z, Feng L, Carolyn GM, et al. Characterizing the epidemiology, virology, and clinical features of influenza in China's first severe acute respiratory infection sentinel surveillance system, February 2011-October 2013. BMC Infect Dis. 2015;15:143.
10. Brottet E, Vandroux D, Gauzere BA, et al. Influenza season in Reunion dominated by influenza B virus circulation associated with numerous cases of severe disease, France, 2014. Euro Surveill. 2014;19:20916.
11. Breiman RF, Cosmas L, Njenga M, et al. Severe acute respiratory infection in children in a densely populated urban slum in Kenya, 2007-2011. BMC Infect Dis. 2015;15:95.
12. World Health Organization. WHO Global Epidemiological Surveil-lance Standards for Influenza. Geneva: World Health Organization; 2014. [2015-8-1].
13. Chinese National Influenza Center. Influenza Surveillance Program for Mainland China, 2010. Beijing: Chinese National Influenza Center; 2010. [2015-8-1].
14. Zhou B, Lin X, Wang W, et al. Universal influenza B virus genomic amplification facilitates sequencing, diagnostics, and reverse genetics. J Clin Microbiol. 2014;52:1330-1337.
15. Tamura K, Stecher G, Peterson D, et al. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30:2725-2729.
16. Drummond AJ, Suchard MA, Xie D, et al. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol. 2012;29:1969-1973.
17. Wang X, Wu S, Macintyre CR, et al. Using an adjusted Serfling regression model to improve the early warning at the arrival of peak timing of influenza in Beijing. PLoS One. 2015;10:e119923.
18. Cheng X, Tan Y, He M, et al. Epidemiological dynamics and phylogeography of influenza virus in southern China. J Infect Dis. 2013;207:106-114.
19. World Health Organization. Influenza (Seasonal). Geneva: World Health Organization; 2014. [2015-8-1].
20. Lunelli A, Rizzo C, Puzelli S, et al. Understanding the dynamics of seasonal influenza in Italy: incidence, transmissibility and population susceptibility in a 9-year period. Influenza Other Respir Viruses. 2013;7:286-295.
21. Tan Y, Guan W, Lam TT, et al. Differing epidemiological dynamics of influenza B virus lineages in Guangzhou, southern China, 2009-2010. J Virol. 2013;87:12447-12456.
22. Socan M, Prosenc K, Ucakar V, et al. A comparison of the demographic and clinical characteristics of laboratory-confirmed influenza B Yamagata and Victoria lineage infection. J Clin Virol. 2014;61:156-160.
23. International Network for Strategic Initiatives in Global HIV Trials (INSIGHT). FLU 003: Baseline Characteristics by Influenza Sub-type, 2015-10-30, Richard T, Dominic D, Marcelo HL, et al. International Network for Strategic Initiatives in Global HIV Trials (INSIGHT). FLU 003: Baseline Characteristics by Influenza Sub-type, 2015-10-30, Twin Cities: International Network for Strategic Initiatives in Global HIV Trials; 2015. http://insight.ccbr.umn.edu/index.php?study=insight&page=&menu=FLU-studies.
24. Peasah SK, Azziz-Baumgartner E, Breese J, et al. Influenza cost and cost-effectiveness studies globally: a review. Vaccine. 2013;31:5339-5348.
25. Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine. 2007;25:6852-6862.
26. Wu SS, Yang P, Li HY, et al. The coverage rate and obstructive factors of influenza vaccine inoculation among residents aged above 18 years in Beijing from 2007 to 2010[in Chinese]. Zhonghua Yu Fang Yi Xue Za Zhi. 2011;45:1077-1081.
27. World Health Organization. Recommended composition of influenza virus vaccines for use in the northern hemisphere 2015-16 influenza season and development of candidate vaccine viruses for pandemic preparedness. Geneva: World Health Organization; 2015. [2015-8-10].
28. Caini S, Huang QS, Ciblak MA, et al. Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study. Influenza Other Respir Viruses. 2015;9:3-12.
29. Meier G, Gregg M, Poulsen NB. Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the UK. J Med Econ. 2015;1:1-16.